You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DARA

Showing 1 - 25 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

Not yet recruiting
  • Multiple Myeloma
  • Dara-VRd intensification, Dara-R maintenance
  • +4 more
  • (no location specified)
Dec 13, 2022

Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

Not yet recruiting
  • Multiple Myeloma
  • Renal Failure
  • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
  • Augusta, Georgia
    Georgia Cancer Center-Augusta University
Nov 16, 2023

Relapsed or Refractory Multiple Myeloma Trial (Daratumumab, Pomalidomide)

Withdrawn
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Jan 26, 2023

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)

Recruiting
  • Multiple Myeloma
  • Torino, TO, Italy
    Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022

Multiple Myeloma Trial (Daratumumab, Cyclophosphamide, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 8, 2021

Maintenance With Bortezomib Plus Daratumumab After Induction

Recruiting
  • Multiple Myeloma
  • Non-eligible for Autologous Stem Cell Transplantation (ASCT)
  • Arganda Del Rey, Spain
  • +31 more
Sep 15, 2022

Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 29, 2022

Multiple Myeloma Trial (Pembrolizumab)

Withdrawn
  • Multiple Myeloma
  • (no location specified)
Apr 20, 2022

Plasma Cell Myeloma Trial in Philadelphia (Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life

Not yet recruiting
  • Plasma Cell Myeloma
  • Daratumumab and Hyaluronidase-fihj
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 19, 2022

Multiple Myeloma Trial (Dara-SC, Blood for research assessments, Bone marrow for research assessments)

Withdrawn
  • Multiple Myeloma
  • Dara-SC
  • +2 more
  • (no location specified)
Jan 6, 2022

Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

Recruiting
  • Aplastic Anemia
  • Bone Marrow Failure Syndrome
  • Anti-Thymocyte Globulin (Rabbit)
  • +8 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 26, 2022

Plasma Cell Myeloma Trial (Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone)

Not yet recruiting
  • Plasma Cell Myeloma
  • (no location specified)
Dec 22, 2022

Multiple Myeloma Trial in United States (Daratumumab, Cyclophosphamide, Bortezomib)

Completed
Has Results
  • Multiple Myeloma
  • Mobile, Alabama
  • +25 more
Oct 7, 2021

High-risk Smoldering Multiple Myeloma, Multiple Myeloma Trial in Boston (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • High-risk Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Oct 18, 2021

Newly Diagnosed Multiple Myeloma Trial (Daratumumab)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • (no location specified)
Oct 10, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (Bortezomib, Daratumumab and Hyaluronidase-fihj,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 30, 2021

Sentinel Lymph Node Biopsy in Early-Stage, Palpable

Recruiting
  • Breast Cancer
  • Breast surgery
  • Hartford, Connecticut
  • +9 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone, Bortezomib)

Terminated
  • Multiple Myeloma
  • Melphalan flufenamide (Melflufen)
  • +3 more
  • Boston, Massachusetts
  • +15 more
Mar 4, 2022

Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

Not yet recruiting
  • Multiple Myeloma
  • Miami, Florida
    University of Miami
Oct 20, 2023

High-Risk de Novo Multiple Myeloma Trial in Spain (Daratumumab, Bortezomib, Lenalidomide)

Not yet recruiting
  • High-Risk de Novo Multiple Myeloma
  • Badalona, Spain
  • +9 more
Apr 27, 2023

Multiple Myeloma Trial in Taiyuan (CD19-CD22 CAR-T cells)

Recruiting
  • Multiple Myeloma
  • CD19-CD22 CAR-T cells
  • Taiyuan, Shanxi, China
    Hematology Department of ShanXi Cancer Hospital
Jan 17, 2021

Lymphoma, B-Cell Trial in Taiyuan (CD19-CD22 CAR-T cells)

Recruiting
  • Lymphoma, B-Cell
  • CD19-CD22 CAR-T cells
  • Taiyuan, Shanxi, China
    Hematology Department of ShanXi Cancer Hospital
Jan 17, 2021

Acute Lymphocytic Leukemia, B-Cell Trial in Taiyuan (CD19-CD22 CAR-T cells)

Recruiting
  • Acute Lymphocytic Leukemia， B-Cell
  • CD19-CD22 CAR-T cells
  • Taiyuan, Shanxi, China
    Hematology Department of ShanXi Cancer Hospital
Jan 17, 2021

Multiple Myeloma Trial in Worldwide (Carfilzomib 20 mg/m^2, Carfilzomib 70 mg/m^2, Dexamethasone 40 mg)

Active, not recruiting
  • Multiple Myeloma
  • Carfilzomib 20 mg/m^2
  • +4 more
  • Gilbert, Arizona
  • +107 more
Dec 20, 2022